Well, I will step back and just watch this one a
Post# of 93
watch this one after looking at
the 10-K.
I can't predict a thing about its business model.
Compounding pharmacies for humans and animals.
They are going to create 3 subsidiaries.
Their share structure remains solid though.
As of April 14, 2017, the registrant had
17,213,894 shares outstanding